Introduction: This systematic review aims to synthesize
evidence for use of repetitive transcranial magnetic stimulation (rTMS)
in recently diagnosed psychotic disorders to determine whether rTMS
could be an effective treatment for early psychosis. Methods:
PubMed, CINAHL, and PsycInfo were searched to obtain relevant articles
published between 2012 and 2023. The Preferred Reporting Items for
Systematic Reviews and Meta-Analysis (PRISMA) Articles was used as a
guideline for reporting. Two authors independently screened articles
using inclusion/exclusion criteria. Those meeting criteria were examined
in detail, with bias scoring via the Cochrane Risk of Bias tool.
Results: Of 2155 articles yielded from the initial search,
fifteen ultimately met inclusion/exclusion criteria and were examined
further. Most of the studies used the PANSS to assess outcome, and the
majority (89%) reported significant effects on negative symptoms
following rTMS, with mixed outcomes for positive symptoms. The most
common neural target for stimulation was the dorsolateral prefrontal
cortex. Seventy-three percent of articles examined neural correlates of
outcome, linking outcome to functional connectivity, grey matter volume,
and BDNF levels. The majority of studies were rated as some or high
bias, due to lack of rigorous controls, lack of blinding, or lack of
randomization. Conclusions: Our systematic review suggests that
rTMS is effective for treatment of negative symptoms of early psychosis.
Negative symptoms are of particular clinical import as a treatment
target, given their impact on function, their resistance to conventional
treatments, and prognostic significance. Limitations and future
directions are discussed.